Cargando…
Two Years of Viral Metagenomics in a Tertiary Diagnostics Unit: Evaluation of the First 105 Cases
Metagenomic next-generation sequencing (mNGS) can capture the full spectrum of viral pathogens in a specimen and has the potential to become an all-in-one solution for virus diagnostics. To date, clinical application is still in an early phase and limitations remain. Here, we evaluated the impact of...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6770117/ https://www.ncbi.nlm.nih.gov/pubmed/31470675 http://dx.doi.org/10.3390/genes10090661 |
_version_ | 1783455396335190016 |
---|---|
author | Kufner, Verena Plate, Andreas Schmutz, Stefan Braun, Dominique L. Günthard, Huldrych F. Capaul, Riccarda Zbinden, Andrea Mueller, Nicolas J. Trkola, Alexandra Huber, Michael |
author_facet | Kufner, Verena Plate, Andreas Schmutz, Stefan Braun, Dominique L. Günthard, Huldrych F. Capaul, Riccarda Zbinden, Andrea Mueller, Nicolas J. Trkola, Alexandra Huber, Michael |
author_sort | Kufner, Verena |
collection | PubMed |
description | Metagenomic next-generation sequencing (mNGS) can capture the full spectrum of viral pathogens in a specimen and has the potential to become an all-in-one solution for virus diagnostics. To date, clinical application is still in an early phase and limitations remain. Here, we evaluated the impact of viral mNGS for cases analyzed over two years in a tertiary diagnostics unit. High throughput mNGS was performed upon request by the treating clinician in cases where the etiology of infection remained unknown or the initial differential diagnosis was very broad. The results were compared to conventional routine testing regarding outcome and workload. In total, 163 specimens from 105 patients were sequenced. The main sample types were cerebrospinal fluid (34%), blood (33%) and throat swabs (10%). In the majority of the cases, viral encephalitis/meningitis or respiratory infection was suspected. In parallel, conventional virus diagnostic tests were performed (mean 18.5 individually probed targets/patients). mNGS detected viruses in 34 cases (32%). While often confirmatory, in multiple cases, the identified viruses were not included in the selected routine diagnostic tests. Two years of mNGS in a tertiary diagnostics unit demonstrated the advantages of a single, untargeted approach for comprehensive, rapid and efficient virus diagnostics, confirming the utility of mNGS in complementing current routine tests. |
format | Online Article Text |
id | pubmed-6770117 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-67701172019-10-30 Two Years of Viral Metagenomics in a Tertiary Diagnostics Unit: Evaluation of the First 105 Cases Kufner, Verena Plate, Andreas Schmutz, Stefan Braun, Dominique L. Günthard, Huldrych F. Capaul, Riccarda Zbinden, Andrea Mueller, Nicolas J. Trkola, Alexandra Huber, Michael Genes (Basel) Article Metagenomic next-generation sequencing (mNGS) can capture the full spectrum of viral pathogens in a specimen and has the potential to become an all-in-one solution for virus diagnostics. To date, clinical application is still in an early phase and limitations remain. Here, we evaluated the impact of viral mNGS for cases analyzed over two years in a tertiary diagnostics unit. High throughput mNGS was performed upon request by the treating clinician in cases where the etiology of infection remained unknown or the initial differential diagnosis was very broad. The results were compared to conventional routine testing regarding outcome and workload. In total, 163 specimens from 105 patients were sequenced. The main sample types were cerebrospinal fluid (34%), blood (33%) and throat swabs (10%). In the majority of the cases, viral encephalitis/meningitis or respiratory infection was suspected. In parallel, conventional virus diagnostic tests were performed (mean 18.5 individually probed targets/patients). mNGS detected viruses in 34 cases (32%). While often confirmatory, in multiple cases, the identified viruses were not included in the selected routine diagnostic tests. Two years of mNGS in a tertiary diagnostics unit demonstrated the advantages of a single, untargeted approach for comprehensive, rapid and efficient virus diagnostics, confirming the utility of mNGS in complementing current routine tests. MDPI 2019-08-29 /pmc/articles/PMC6770117/ /pubmed/31470675 http://dx.doi.org/10.3390/genes10090661 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Kufner, Verena Plate, Andreas Schmutz, Stefan Braun, Dominique L. Günthard, Huldrych F. Capaul, Riccarda Zbinden, Andrea Mueller, Nicolas J. Trkola, Alexandra Huber, Michael Two Years of Viral Metagenomics in a Tertiary Diagnostics Unit: Evaluation of the First 105 Cases |
title | Two Years of Viral Metagenomics in a Tertiary Diagnostics Unit: Evaluation of the First 105 Cases |
title_full | Two Years of Viral Metagenomics in a Tertiary Diagnostics Unit: Evaluation of the First 105 Cases |
title_fullStr | Two Years of Viral Metagenomics in a Tertiary Diagnostics Unit: Evaluation of the First 105 Cases |
title_full_unstemmed | Two Years of Viral Metagenomics in a Tertiary Diagnostics Unit: Evaluation of the First 105 Cases |
title_short | Two Years of Viral Metagenomics in a Tertiary Diagnostics Unit: Evaluation of the First 105 Cases |
title_sort | two years of viral metagenomics in a tertiary diagnostics unit: evaluation of the first 105 cases |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6770117/ https://www.ncbi.nlm.nih.gov/pubmed/31470675 http://dx.doi.org/10.3390/genes10090661 |
work_keys_str_mv | AT kufnerverena twoyearsofviralmetagenomicsinatertiarydiagnosticsunitevaluationofthefirst105cases AT plateandreas twoyearsofviralmetagenomicsinatertiarydiagnosticsunitevaluationofthefirst105cases AT schmutzstefan twoyearsofviralmetagenomicsinatertiarydiagnosticsunitevaluationofthefirst105cases AT braundominiquel twoyearsofviralmetagenomicsinatertiarydiagnosticsunitevaluationofthefirst105cases AT gunthardhuldrychf twoyearsofviralmetagenomicsinatertiarydiagnosticsunitevaluationofthefirst105cases AT capaulriccarda twoyearsofviralmetagenomicsinatertiarydiagnosticsunitevaluationofthefirst105cases AT zbindenandrea twoyearsofviralmetagenomicsinatertiarydiagnosticsunitevaluationofthefirst105cases AT muellernicolasj twoyearsofviralmetagenomicsinatertiarydiagnosticsunitevaluationofthefirst105cases AT trkolaalexandra twoyearsofviralmetagenomicsinatertiarydiagnosticsunitevaluationofthefirst105cases AT hubermichael twoyearsofviralmetagenomicsinatertiarydiagnosticsunitevaluationofthefirst105cases |